Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jan 29;17(1):F77-89.
doi: 10.1677/ERC-09-0203. Print 2010 Mar.

MicroRNAs in ovarian carcinomas

Neetu Dahiya  1 , Patrice J Morin
Affiliations
Review

MicroRNAs in ovarian carcinomas

Neetu Dahiya et al. Endocr Relat Cancer. .

Abstract

The molecular mechanisms involved in epithelial ovarian cancer initiation and progression are just beginning to be elucidated. In particular, it has become evident that microRNAs (miRNAs or miRs), a class of molecules that post-transcriptionally regulate gene expression, play a major role in ovarian tumorigenesis. Several microRNA profiling studies have identified changes in microRNA patterns that take place during ovarian cancer development. While most deregulated microRNAs are down-regulated in cancer, and may therefore act as tumor suppressors, others are elevated and may represent novel oncogenes in this disease. A number of microRNAs identified as aberrantly expressed in ovarian carcinoma have been shown to have important functional roles in cancer development and may therefore represent targets for therapy. In addition, some of the microRNA patterns may have prognostic significance. The identification of functional targets represents a major hurdle in our understanding of microRNA function in ovarian carcinoma, but significant progress is being made. It is hoped that a better understanding of the microRNA expression and roles in ovarian cancer may provide new avenues for the detection, diagnosis, and therapy of this deadly disease.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of this review.

Figures

Figure 1
Figure 1
Schematic representation of selected known targets for miRNAs that are frequently altered in ovarian carcinoma. The miRNAs frequently down-regulated in ovarian carcinoma (shown in green boxes) typically target genes that have growth promoting functions, while miRNAs that are up-regulated (red boxes) target genes that have negative effects on cell growth. These miRNAs may represent targets for therapeutic interventions.
Figure 2
Figure 2
MiRNAs with potential clinical use in ovarian carcinoma. List of miRNAs with potential roles in recurrence/drug resistance (Laios et al. 2008; Yang et al. 2008a; Yang, et al. 2008b), diagnosis/detection (Shell et al. 2007; Shen et al. 2008), prognosis (Nam et al. 2008a; Yang et al. 2008a; Zhang et al. 2008) of ovarian cancer. MiRNAs indicated in green are typically down-regulated in ovarian carcinoma, while miRNAs indicated in red are up-regulated.
See this image and copyright information in PMC

References

    1. Ahmed FY, Wiltshaw E, Ahern RP, Nicol B, Shepherd J, Blake P, Fisher C, Gore ME. Natural history and prognosis of untreated stage I epithelial ovarian carcinoma. J Clin Onc. 1996;14:2968–2975. - PubMed
    1. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature. 2008;455:64–71. - PMC - PubMed
    1. Barik S. An intronic microRNA silences genes that are functionally antagonistic to its host gene. Nucleic Acids Res. 2008;36:5232–5241. - PMC - PubMed
    1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. - PubMed
    1. Bartels CL, Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer. Clin Chem. 2009;55:623–631. - PubMed

Publication types

MeSH terms